FIELD: medicine.
SUBSTANCE: invention relates to medicine. Method of treating nonresectable and potentially resectable metastases of colorectal cancer in the liver involves high-power brachytherapy with a radiation source of 192Ir on an afterloading system. Under the helical computed tomography navigation with the preliminary intravenous introduction of the iodine-containing contrast in amount of 50–100 ml or under ultrasonic guidance in the metastatic center, introducers are introduced every 5–8 mm for high-power brachytherapy with diameter of 6 Fr. Control is performed by means of spiral computed tomography with thickness of cuts of 5 mm, after which the introducers are fixed to the patient's skin, wherein the position of the introducers is taken as a coordinate system x, y, z and encoded using the BrachyVision software as a reference point system, then high-power brachytherapy is performed with radiation source Ir192 with activity of 10 Ci, and in one session on a metastatic center dose is 20 Gy, after which the introducers are removed, and the puncture canals are sealed with haemostatic glue, with further control every 6 weeks and then every 3 months for next 3 years.
EFFECT: technical result of the declared invention consists in increasing the percentage of partial or complete regression of metastatic centers.
1 cl, 3 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF HIGH-POWER BRACHYTHERAPY OF LOCALLY ADVANCED PANCREATIC CANCER | 2020 |
|
RU2738652C2 |
METHOD FOR INTERSTITIAL, HIGH-POWER BRACHYTHERAPY OF LOCALLY ADVANCED SMALL PELVIS TUMORS HAVING A LATERAL INVASION OF A SMALL PELVIS WALL | 2019 |
|
RU2719935C2 |
METHOD OF COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE LIVER METASTASES | 2023 |
|
RU2813334C1 |
METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE LIVER METASTASES IN ABSENCE OF MUTATIONS IN KRAS GENES | 2023 |
|
RU2819653C1 |
METHOD OF THE COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE LIVER METASTASES IN THE PRESENCE OF MUTATIONS IN THE KRAS GENES | 2023 |
|
RU2797847C1 |
METHOD FOR COMPLEX HORMONE-CHEMORADIATION TREATMENT OF LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER OF HIGH AND VERY HIGH RISK OF PROGRESSING | 2019 |
|
RU2716942C2 |
METHOD FOR THE TREATMENT OF UNRESECTABLE HYLUS CHOLANGIOCARCINOMA | 2020 |
|
RU2755329C2 |
METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE HEPATIC METASTASES AND IN THE ABSENCE OF MUTATIONS IN THE KRAS AND BRAF GENES | 2021 |
|
RU2764955C1 |
METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE HEPATIC METASTASES AND IN PRESENCE OF MUTATIONS IN KRAS AND BRAF GENES | 2021 |
|
RU2760174C1 |
METHOD FOR TREATMENT OF MALIGNANT NEUROENDOCRINAL TUMOURS OF PANCREAS HEAD WITH METASTASES IN LIVER | 2016 |
|
RU2625275C1 |
Authors
Dates
2020-05-29—Published
2019-08-16—Filed